Biography and Research Information
OverviewAI-generated summary
Robin Eluvathingal's research investigates methods to enhance the effectiveness of cancer radiation therapy. Their work has explored targeting Cyclin-Dependent Kinase 1 (CDK1) to increase radiosensitivity in pancreatic cancer. Additionally, Eluvathingal has studied the potential of methionine restriction as a strategy to radiosensitize KRAS mutant rectal cancer. These studies indicate a focus on molecular mechanisms underlying cancer treatment response. Eluvathingal collaborates with researchers at the University of Arkansas for Medical Sciences and the University of Central Arkansas, with two shared publications with Stetson Van Matre.
Metrics
- Publications: 2
Selected Publications
-
Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023)
Collaboration Network
Top Collaborators
Adam R. Wolfe
2 shared publications
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- OC-0427 Targeting Cyclin-Dependent Kinase 1 to Radiosensitize Pancreatic Cancer
Stetson Van Matre
2 shared publications
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
- OC-0427 Targeting Cyclin-Dependent Kinase 1 to Radiosensitize Pancreatic Cancer
Sarita Garg
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
Oscar Zuniga
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
Henrique Rodrigues
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
Nükhet Aykin‐Burns
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
Isabelle R. Miousse
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer
O. Zuniga
1 shared publication
- OC-0427 Targeting Cyclin-Dependent Kinase 1 to Radiosensitize Pancreatic Cancer
H. Rodrigues
1 shared publication
- OC-0427 Targeting Cyclin-Dependent Kinase 1 to Radiosensitize Pancreatic Cancer
X Y Feng
1 shared publication
- OC-0427 Targeting Cyclin-Dependent Kinase 1 to Radiosensitize Pancreatic Cancer
Similar Researchers
Based on overlapping research topics
Stetson Van Matre
University of Central Arkansas
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Diet and metabolism studies
Lokesh Akana
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Diet and metabolism studies
Oscar Zuniga
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Diet and metabolism studies
Henrique Rodrigues
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Diet and metabolism studies
Lee, Seongok
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Radiation Therapy and Dosimetry
Ann R. Henry
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research